Master Cell Bank Clonality Assessment via Sequencing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining the clonality of Master Cell Banks (MCBs) are labor-intensive and time-consuming, often relying on techniques like FISH and Southern blot analysis, which lack sensitivity, especially in cell lines with low copy numbers or multiple insertion sites, complicating regulatory approval processes for pharmaceutical proteins.
Innovation Solution
A method involving paired-end sequencing to identify and compare transgene insertion regions in reference and subclone cells, using sequence coverage to determine monoclonality, allowing for reliable assessment of clonality through bioinformatic analysis and matrix representation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional methods like FISH and Southern blot analysis are used to determine clonality, then the assessment can be performed with existing techniques, but the process becomes labor-intensive and time-consuming
Solution Approach 1:
The patent replaces manual, mechanical laboratory techniques (FISH, Southern blot) with automated next-generation sequencing technology. The sequencing process automatically identifies transgene insertion sites through high-throughput DNA sequencing and bioinformatic analysis, eliminating the need for labor-intensive manual probe hybridization and gel electrophoresis while providing more comprehensive genomic coverage
Solution Approach 2:
The patent changes the detection parameter from visual/manual analysis of hybridization patterns to digital sequence read analysis. By sequencing the genome at high depth and analyzing the digital data through bioinformatic pipelines, the system achieves faster, more objective, and more sensitive detection of transgene insertion sites, transforming the assessment from a qualitative manual process to a quantitative automated one
2Measurement precision
If traditional methods like FISH and Southern blot analysis are used to determine clonality, then the assessment can be performed with existing techniques, but the sensitivity is insufficient especially in cell lines with low copy numbers or multiple insertion sites
Solution Approach 1:
The patent segments the genome into individual transgene insertion sites by sequencing and analyzing each site independently. The bioinformatic pipeline identifies and catalogs each insertion site separately, allowing precise detection even when multiple insertions exist. This segmentation approach enables the system to resolve complex genomic architectures with multiple low-copy insertions that traditional methods cannot distinguish
Solution Approach 2:
The patent creates multiple digital copies of the genomic region through high-depth sequencing, generating numerous sequence reads that cover each transgene insertion site. This copying effect amplifies the signal from low-copy number insertions, making them detectable through bioinformatic analysis of the accumulated sequence data, whereas traditional methods rely on single hybridization events that may miss low-abundance targets
3Productivity
If next-generation sequencing is used to identify transgene insertion regions, then clonality assessment becomes faster and more reliable, but the sequence coverage and depth requirements increase
Solution Approach 1:
The patent applies partial sequencing coverage strategically focused on regions containing transgene insertions rather than uniformly sequencing the entire genome at high depth. The bioinformatic pipeline identifies insertion sites using moderate coverage and then focuses additional sequencing or analysis resources on those specific regions, achieving sufficient sensitivity without the excessive resource requirements of whole-genome high-depth sequencing
Data Source
AI summary
The invention relates to a method for determining the clonality of a master cell bank (MCB) in which a transgene has been inserted. The method involves a combination of sequencing methodology and bioinformatic analysis, performed on multiple subclones originating from a common MCB, to establish a reliable set of reference transgene insertion regions in one reference subclone, and corresponding sets of comparative transgene insertion regions in one or more other subclones originating from the same MCB. Based on the degree of congruity between reference and comparative transgene insertion regions, the MCB is determined to be either monoclonal or polyclonal.